March 22, 2016

Press Release: Precision for Medicine to Acquire ACT Oncology

Establishes Leading Platform for Precision Medicine Oncology Research Bethesda, Md. and Flemington, N.J., March 22, 2016 – Precision for Medicine, part of the Precision Medicine Group, announced today that it has executed a binding agreement to acquire ACT Oncology, the leading contract research organization (CRO) specializing exclusively in the field […]
Do you like it?
Read more
Prev page
12345678910111213141516171819202122232425262728293031323334353637383940414243444546
Next page

Precision for Medicine is part of the Precision Medicine Group, an integrated team of experts that extends Precision for Medicine’s therapeutic development capabilities beyond approval and into launch strategies, marketing communication, and payer insights. As one company, the Precision Medicine Group helps pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

Visit the website